News | January 28, 2022
Lupin signs promotional agreement with Exeltis on SOLOSEC
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
UCB plans to submit regulatory applications in Q3 2022
However, these won’t be available at the nearest chemist store soon
The companies were evaluated via a comprehensive, in-depth assessment process that included a sustainability framework of 300 points each for – Purpose, Partnership, Planet and People
Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer
He has more than 285 publications with 7,600 citations, 80 students have already been awarded Ph. D. degree under his able guidance and 20 postdoctoral associates have worked in his group
The first hospital in Kharadi launched three years ago has made a significant difference to women and children's health
Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
Subscribe To Our Newsletter & Stay Updated
